North America Endovenous Laser Therapy Market

The size of the North America Endovenous Laser Therapy market was around USD 94.86 million in 2023. It is expected to grow at a CAGR of 7% to reach USD 133.04 million by 2028. It captures 35% of the global market share.

The rising occurrence of varicose veins is likely to drive the North American endovenous laser therapy market. According to the American Vein and Lymphatic Society, more than 40 million people in the United States have varicose veins. Additionally, the growing population, associated lifestyles, and dietary habits that lead to obesity and other problems are further estimated to boost the market's growth rate. Furthermore, North America witnessed technological advancements in the healthcare sector in the recent past; the adoption of endogenous laser ablation to treat lower-extremity chronic venous disease is expected to accelerate the market’s growth rate. 

The growing population is considered one of the significant growth contributors to the market. Furthermore, as varicose is a common condition, it influences the market growth. Growing research and development activities related to ELT and ELA are projected to offer significant growth opportunities to the market growth.  The increasing awareness among the people influences the demand for endo-venous laser therapy. Increasing investments and funding by the government in research and development activities is encouraging market growth. 

The key market player operating in the market are implementing various market strategies to gain a competitive advantage over the marketplace. The market strategies include partnerships, mergers, and acquisitions.

However, the availability of alternative therapies is expected to hinder the growth of the North American endovenous laser therapy market. Unlike previous treatment methods for venous reflux, commonly known as chronic venous insufficiency, the approach described above does not necessitate multiple anesthetic injections. Furthermore, complications connected with ELT are projected to impede the market growth. Skin burns, nerve injury, bruising, deep venous thrombosis, transient numbness, pulmonary embolism, and a sensation of tightness are other ELT consequences.

This research report on the North American Endovenous Laser Therapy market has been segmented and sub-segmented into the following categories.

By Technology:

• Endovenous Laser Systems             
  • Diode Lasers
  • YAG Lasers
• Endovenous Laser Fibres  
  • Bare Tip Laser Fibre
  • Radial Tip Laser Fibre
  • Gold Tip Laser Fibre

By End User:

• Hospitals   
• Clinics   
• Ambulatory Centers

By Country:

• The United States
• Canada
• Rest of North America

Geographically, North America dominated the global endovenous laser therapy market in 2022, and it is more likely to continue its dominance throughout the forecast period. Key market players, favorable reimbursement policies, and increasing research and development expenditure propel market growth. In addition, the Y-O-Y growing prevalence of obesity population is boosting the Endovenous Laser therapy market. 

The U.S. accounted for the largest share of the North American market in 2022, and it is anticipated to register a predominant share during the forecast period. Although endovenous laser therapy has become a popular treatment for varicose veins in the United States, the growing awareness among the people is uplifting the market. Further, the market growth is attributed to the increasing occurrence of varicose veins, technological advancements, and well-established healthcare infrastructure. 

On the other hand, Canada is projected to grow at a promising rate during the forecast period. The significant rise in varicose veins, growing population, increasing demand for endo-venous laser therapy, and the availability of advancing technological products are propelling the market growth. 

KEY MARKET PLAYERS:

Companies playing a significant role in the North American endovenous laser therapy market profiled in this report are Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, AngioDynamics, Inc., Syneron Medical Ltd, Dornier Medtech GmbH, Wontech Co., Ltd, intros Medical Laser GmbH, Energist Ltd among others.